Main Session
Sep
30
SS 36 - GI 3: Liver - Checking in on Inhibitors, inSPECTing Liver Function, and Making Progress Oligo-ly
308 - Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-Line Immunotherapy: A Phase II Clinical Study
Presenter(s)
Shisuo Du, MD, PhD - Zhongshan Hospital Fudan University, Shanghai 200032, Shanghai